JP2001515029A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001515029A5 JP2001515029A5 JP2000509400A JP2000509400A JP2001515029A5 JP 2001515029 A5 JP2001515029 A5 JP 2001515029A5 JP 2000509400 A JP2000509400 A JP 2000509400A JP 2000509400 A JP2000509400 A JP 2000509400A JP 2001515029 A5 JP2001515029 A5 JP 2001515029A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- polymer
- form according
- soluble
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5619597P | 1997-08-21 | 1997-08-21 | |
| US60/056,195 | 1997-08-21 | ||
| PCT/US1998/015693 WO1999008660A1 (en) | 1997-08-21 | 1998-07-29 | Solid pharmaceutical dosage forms in form of a particulate dispersion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001515029A JP2001515029A (ja) | 2001-09-18 |
| JP2001515029A5 true JP2001515029A5 (cg-RX-API-DMAC10.html) | 2006-01-05 |
Family
ID=22002810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000509400A Abandoned JP2001515029A (ja) | 1997-08-21 | 1998-07-29 | 粒状分散形態の固形医薬剤形 |
Country Status (17)
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2111065T5 (es) * | 1991-04-16 | 2005-06-16 | Nippon Shinyaku Company, Limited | Procedimiento para producir una dispersion solida. |
| JPH06511291A (ja) * | 1991-08-02 | 1994-12-15 | ウィルコム タフティング ピーティーワイ リミテッド | 房付け方法及び房付けシステム |
| US7045519B2 (en) | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| US20040102486A1 (en) * | 1998-11-12 | 2004-05-27 | Smithkline Beecham Corporation | Novel method of treatment |
| US20030153607A1 (en) * | 1998-11-12 | 2003-08-14 | Smithkline Beecham P.L.C. | Novel composition and use |
| YU43702A (sh) | 1999-12-23 | 2004-11-25 | Pfizer Products Inc. | Farmaceutske kompozicije koje obezbeđuju povećanje koncentracije leka |
| DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
| WO2002024168A1 (fr) * | 2000-09-25 | 2002-03-28 | Nippon Shinyaku Co., Ltd. | Procede de production d'une dispersion solide medicinale |
| ATE293439T1 (de) * | 2000-12-07 | 2005-05-15 | Warner Lambert Co | Verfahren und system zur gleichmä igen arzneistoffabgabe |
| MXPA03011784A (es) | 2001-06-22 | 2004-04-02 | Pfizer Prod Inc | Composiciones farmaceuticas de dispersiones de farmacos y polimeros neutros. |
| GB0127805D0 (en) * | 2001-11-20 | 2002-01-09 | Smithkline Beecham Plc | Pharmaceutical composition |
| DE60320940D1 (de) | 2002-02-01 | 2008-06-26 | Pfizer Prod Inc | Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien |
| GB0205253D0 (en) * | 2002-03-06 | 2002-04-17 | Univ Gent | Immediate release pharmaceutical granule compositions and a continuous process for making them |
| CN1681479A (zh) * | 2002-08-12 | 2005-10-12 | 辉瑞产品公司 | 半有序药物和聚合物的药物组合物 |
| US20050220870A1 (en) * | 2003-02-20 | 2005-10-06 | Bonnie Hepburn | Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
| US20050100608A1 (en) * | 2003-02-21 | 2005-05-12 | Watson Pharmaceuticals, Inc. | Testosterone oral dosage formulations and associated methods |
| GB0315012D0 (en) * | 2003-06-27 | 2003-07-30 | Leuven K U Res & Dev | Zeotiles |
| US8273371B2 (en) * | 2003-06-27 | 2012-09-25 | Johan Adriaan Martens | Crystalline mesoporous oxide based materials useful for the fixation and controlled release of drugs |
| CA2531564C (en) * | 2003-07-18 | 2016-01-19 | Santarus, Inc. | Pharmaceutical composition for inhibiting acid secretion |
| US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| JP2007501218A (ja) | 2003-08-04 | 2007-01-25 | ファイザー・プロダクツ・インク | 非晶質薬物の吸着物および親油性ミクロ相形成物質の医薬組成物 |
| US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
| US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
| RU2331410C2 (ru) * | 2003-12-04 | 2008-08-20 | Пфайзер Продактс Инк. | Способ получения фармацевтических мультичастиц |
| EP1718303A4 (en) * | 2004-02-10 | 2010-09-01 | Santarus Inc | COMBINATION OF INHIBITOR OF PROTON PUMP, BUFFER AND NON-STEROIDAL ANTI-INFLAMMATORY DRUG |
| US20050202079A1 (en) * | 2004-03-15 | 2005-09-15 | Mylan Pharmaceuticals Inc. | Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation |
| US8815916B2 (en) | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| EP1817008B1 (en) | 2004-11-09 | 2020-04-01 | Board of Regents, The University of Texas System | Stabilized hme composition with small drug particles |
| DE102004062475A1 (de) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung |
| DK1830817T3 (da) * | 2004-12-30 | 2013-04-02 | Pf Medicament | Stabil, fast dispersion af et derivat af vinca-alkaloid og fremgangsmåde til fremstilling heraf |
| US20060147518A1 (en) * | 2004-12-30 | 2006-07-06 | Pierre Fabre Medicament | Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it |
| FR2880274B1 (fr) * | 2004-12-30 | 2007-04-13 | Pierre Fabre Medicament Sa | Dispersion solide stable d'un derive d'alcaloides de vinca et son procede de fabrication |
| NZ585116A (en) * | 2005-05-10 | 2011-12-22 | Novartis Ag | Extrusion process for making compositions with poorly compressible therapeutic compounds e.g. metformin hydrochloride |
| GB0612695D0 (en) * | 2006-06-27 | 2006-08-09 | Univ Gent | Process for preparing a solid dosage form |
| JP2010513324A (ja) * | 2006-12-21 | 2010-04-30 | アルファファーム ピーティーワイ リミテッド | 医薬化合物および医薬組成物 |
| PT2309987E (pt) * | 2008-07-03 | 2012-12-13 | Novartis Ag | Processo para granulação por fusão |
| WO2010136604A1 (en) * | 2009-05-29 | 2010-12-02 | Dsm Ip Assets B.V. | Transfer matrix for transferring a bioactive agent to body tissue |
| CN103391769A (zh) | 2011-02-17 | 2013-11-13 | 霍夫曼-拉罗奇有限公司 | 通过热熔挤出使活性药物成分从过冷液体状态受控结晶的方法 |
| CA2848493A1 (en) | 2011-09-14 | 2013-03-21 | Celgene Corporation | Formulations of cyclopropanecarboxylic acid {2-[(1s)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1h-isoindol-4-yl}-amide |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6038322A (ja) * | 1983-08-11 | 1985-02-27 | Fujisawa Pharmaceut Co Ltd | ジヒドロピリジンa物質含有易溶性固形製剤 |
| JPH054919A (ja) * | 1990-07-25 | 1993-01-14 | Sankyo Co Ltd | チアゾリジン誘導体の固体分散体 |
| ES2111065T5 (es) * | 1991-04-16 | 2005-06-16 | Nippon Shinyaku Company, Limited | Procedimiento para producir una dispersion solida. |
| SG43179A1 (en) * | 1991-12-18 | 1997-10-17 | Warner Lambert Co | A process for the prepatation of a solid dispersion |
| US5340591A (en) * | 1992-01-24 | 1994-08-23 | Fujisawa Pharmaceutical Co., Ltd. | Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine |
| DE4226753A1 (de) * | 1992-08-13 | 1994-02-17 | Basf Ag | Wirkstoffe enthaltende Zubereitungen in Form fester Teilchen |
| JPH07324086A (ja) * | 1994-05-31 | 1995-12-12 | Sankyo Co Ltd | チアゾリジン誘導体の固体分散体または固体分散体製剤 |
| DE19515972A1 (de) * | 1995-05-02 | 1996-11-07 | Bayer Ag | Arzneizubereitungen mit kontrollierter Freisetzung und Verfahren zu ihrer Herstellung |
-
1998
- 1998-07-24 HN HN1998000115A patent/HN1998000115A/es unknown
- 1998-07-29 WO PCT/US1998/015693 patent/WO1999008660A1/en not_active Ceased
- 1998-07-29 EP EP98937241A patent/EP1011640A1/en not_active Withdrawn
- 1998-07-29 NZ NZ502869A patent/NZ502869A/xx unknown
- 1998-07-29 AU AU86000/98A patent/AU8600098A/en not_active Abandoned
- 1998-07-29 KR KR1020007001704A patent/KR20010023085A/ko not_active Ceased
- 1998-07-29 BR BR9811972-9A patent/BR9811972A/pt not_active Application Discontinuation
- 1998-07-29 JP JP2000509400A patent/JP2001515029A/ja not_active Abandoned
- 1998-07-29 US US09/284,858 patent/US20010048946A1/en not_active Abandoned
- 1998-07-29 CA CA002292586A patent/CA2292586C/en not_active Expired - Fee Related
- 1998-08-19 AR ARP980104098A patent/AR018252A1/es unknown
- 1998-08-20 CO CO98047585A patent/CO4960652A1/es unknown
- 1998-08-20 ZA ZA987551A patent/ZA987551B/xx unknown
- 1998-08-20 GT GT199800136A patent/GT199800136A/es unknown
- 1998-08-20 PA PA19988458101A patent/PA8458101A1/es unknown
- 1998-08-20 SV SV1998000104A patent/SV1998000104A/es not_active Application Discontinuation
- 1998-08-20 PE PE1998000752A patent/PE109599A1/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2513999B2 (ja) | 口腔又は鼻腔用医薬組成物 | |
| JP3496961B2 (ja) | 有効成分を徐放するための多層マトリックス系 | |
| AU719170B2 (en) | Pharmaceutical compressed tablet characterized by a high increase in volume by contact with biological fluids | |
| CO4960652A1 (es) | Formas de dosificacion farmaceuticas solidas | |
| BG66095B1 (bg) | Хидрофилен състав с контролирано освобождаване съдържащ прежелатинирано нишесте в препарат | |
| CA2301378A1 (en) | Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin | |
| MA25323A1 (fr) | Formes galeniques a delitement rapide en bouche et leur procede de preparation. | |
| TR200003788A2 (tr) | Yavaş salımlı oral dozaj bileşim. | |
| CR7661A (es) | Composicion de comprimido de liberacion sostenida de pramipexol | |
| CA2204180A1 (en) | Melt-extruded orally administrable therapeutically active formulations | |
| DE69726179D1 (de) | Pharmazeutische suspensionssysteme | |
| DE69330672D1 (de) | Pharmazeutische zubereitung zur anwendung in den atemwegen | |
| EP1797873A3 (en) | Compressed microparticles for dry injection | |
| SE9704401D0 (sv) | Matrix pellets for greasy, oily or sticky drug substances | |
| CA2352211A1 (en) | Sustained release matrix systems for highly soluble drugs | |
| IT1270239B (it) | Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo | |
| WO2002024203A3 (en) | Controlled release formulations for oral administration | |
| CA2383212A1 (en) | Controlled release oral dosage suitable for oral administration | |
| HU9301672D0 (en) | Method for manufacturing solid dosing forms of medicaments with controlled releasing of active agents | |
| WO2001013898A3 (en) | Pharmaceutical formulations with different release times | |
| SE9704400D0 (sv) | Porous inorganic particles as carriers for drug substances | |
| RU2002112238A (ru) | Перорально распадающаяся композиция, содержащая миртазапин | |
| AP2001002084A0 (en) | Orally administered controlled delivery system for once daily adminstration of ciprofloxacin | |
| CA2356306A1 (en) | Sulfated phosphatidylinositols, their preparation and use | |
| AU2127400A (en) | A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and process for preparation thereof |